Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice

Indian Journal of Pharmacology

Volumn 48, Issue 6, 2016, Pages 643-648

  Bale, Swarna ^a   Sunkoju, Manoj ^a   Reddy, Shiva Shankar ^a   Swamy, Veerabhadra ^a   Godugu, Chandraiah ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Bleomycin; oropharyngeal aspiration; pulmonary fibrosis

Indexed keywords

ALBUMIN; BLEOMYCIN; GLUTATHIONE; HYDROXYPROLINE; MALONALDEHYDE; NITRIC OXIDE; ANTINEOPLASTIC ANTIBIOTIC; AUTACOID;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG STRUCTURE; LUNG TOXICITY; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; OROPHARYNGEAL DRUG ADMINISTRATION; OXIDATIVE STRESS; WESTERN BLOTTING; ACID ASPIRATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHARYNX;

ADMINISTRATION, ORAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; MALE; MICE; PHARYNX; PULMONARY FIBROSIS; RESPIRATORY ASPIRATION;

EID: 85000933279     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.194859     Document Type: Article

References (20)

1. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature. Eur Respir Rev 2012;21:355-61.
2. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review. Eur Respir J 2015;46:795-806.
3. Reinert T, Baldotto CS, Nunes FA, Scheliga AA. Bleomycin-induced lung injury. J Cancer Res 2013;2013:1-9.
4. Lakatos HF, Burgess HA, Thatcher TH, Redonnet MR, Hernady E, Williams JP, et al. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Exp Lung Res 2006;32:181-99.
5. Egger C, Cannet C, Gérard C, Jarman E, Jarai G, Feige A, et al. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One 2013;8:e63432.
6. Foster WM, Walters DM, Longphre M, Macri K, Miller LM. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol 2001;90:1111-7.
7. De Vooght V, Vanoirbeek JA, Haenen S, Verbeken E, Nemery B, Hoet PH. Oropharyngeal aspiration: An alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology 2009;259:84-9.
8. Wetzel K, Capodieci P, Dowling M, Coote J, et al. Oropharyngeal aspiration as an alternative route of inhaled administration in a mouse model of IL-13 induced goblet cell metaplasia. C74 models and methods in lung biology. Am Thorac Soc 2016;193:AS928. Available from: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1MeetingAbstracts.A5928. Last accessed on 2016 Oct 13].
9. Schully KL, Bell MG, Ward JM, Keane-Myers AM. Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice. PLoS One 2014;9:e115066.
10. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
11. Suzuki Y, Lyall V, Biber TU, Ford GD. A modified technique for the measurement of sulfhydryl groups oxidized by reactive oxygen intermediates. Free Radic Biol Med 1990;9:479-84.
12. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-7.
13. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, et al. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 2000;106:1341-50.
14. Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005;172:417-22.
15. Gurujeyalakshmi G, Wang Y, Giri SN. Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide 2000;4:399-411.
16. Divya T, Dineshbabu V, Soumyakrishnan S, Sureshkumar A, Sudhandiran G. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis. Chem Biol Interact 2016;246:52-62.
17. Thrall RS, Vogel SN, Evans R, Shultz LD. Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 1997;151:1303-10.
18. Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol 1998;64:528-36.
19. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-27.
20. Sheppard D. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-ß activation by epithelial cells and fibroblasts. Ann Am Thorac Soc 2015;12 Suppl 1:S21-3.